Effect of Trailokya Vijya Vati in Various Disease – A Review
DOI:
https://doi.org/10.48165/IRJAY.2024.70909Keywords:
Bambusa arundinacea medicinal property, Cannabis Sativa, Trailokya Vijaya Vati, Vijaya sativaAbstract
Introduction: One of the strongest traditional medicines is Trailokya Vijaya Vati, which contains vijaya as one of its main constituents. “Trailokya Vijaya Vati” means “victory over the outer three worlds” in literal translation. According to Ayurveda, the medication is considered a “Aashukari” or drug that offers immediate comfort since it directly affects motor neurons, or “Vaat-Vaahini Naadi.” Because of this, it offers prompt relief from conditions involving different kinds of pain.
Materials and Methods: Information on trailokya vijya vati in various disease was gathered from the Laghutrayi, the Brihattrayi and its commentaries, and other Ayurvedic and modern texts.
Results: The binary preparation known as Trailokya Vijaya Vati, which combines Vijaya sativa with Bambusa arundianaceae, was initially documented in Rasa Vigyana, a modern Ayurvedic Alchemy and Pharmaceutics treatise. Discussion: Apasmara (seizure disorders), Rajahkashtajanya Shoola (dysmenorrhea and related symptoms), Rajayakshma (tuberculosis and similar wasting diseases), Atisara (diarrhea, colitis, IBS, IBDs, etc.), and Shoola (acute and chronic pains emerging from varied pathologies and origins) are just a few of the plethora of health conditions for which this potent formulation is renowned for producing amazing therapeutic effects.
Conclusion: Trailokya Vijaya Vati improves general health and well-being by balancing the three doshas (Pitta, Kapha, and Vata) in the body
The main constituents in Trailokya Vijaya Vati, a traditional medicine, are Bambusa arundinacea and Vijaya. The Ayurvedic text Rasa Vigyana describes this powerful formulation, which has been shown to have therapeutic effects for a variety of health conditions, such as anxiety, insomnia, seizures, psychological and psychosomatic disorders, dysmenorrhea, diarrhea, tuberculosis, and acute and chronic pain. The medication helps to manage seizures and has a relaxing impact on the brain.[1] Trailokya Vijaya Vati is also effective in relieving neuropathic pain. One kind of persistent pain that results from harm to the nerve system is called neuropathic pain. Trailokya Vijaya Vati’s natural components have the potential to lessen inflammation and ease neuropathic pain. Chemotherapy adverse effects can be effectively mitigated using Trailokya Vijaya Vati. Abdominal pain and renal colic
Downloads
References
Available from: https://www.researchgate.net/
publication/282317397_vijaya_vijaya_sativa_linn_and_its_
therapeutic_importance_in_ayurveda_a_review [Last accessed on
Jun 27].
Available from: https://hempstreet.in/product/trailokya-vijaya-vati
[Last accessed on 2024 Jun 27].
Wedman-St Louis B, editor. Vijaya as Medicine. 1st ed. Boca Raton, FL,
USA, Oxford, UK: CRC Press, Taylor and Francis; 2019.
Russo E. Vijaya in India: Ancient lore and modern medicine. In:
Mechoulam R, editor. Cannabinoids as Therapeutics. Milestones in
Drug Therapy MDT. Basel, Switzerland: Birkhäuser; 2005. p. 1-22.
Touw M. The religious and medicinal uses of Cannabis in China,
India and Tibet. J Psychoactive Drugs 1981;13:23-34.
Acharya SL, Howard J, Panta SB, Mahatma SS, Copeland J.
Cannabis, Lord Shiva and holy men: Cannabis use among Sadhus in
Nepal. J Psychiatr Assoc Nepal 2015;3:9-14.
Godlaski TM. Shiva, Lord of Bhang. Subst Use Misuse
;47:1067-72.
Mücke M, Phillips T, Radbruch L, Petzke F, Häuser W. Cannabis-
based medicines for chronic neuropathic pain in adults. Cochrane
Database Syst Rev 2018;3:CD012182.
Available from: https://www.cancer.gov/about-cancer/understanding/
what-is-cancer [Last accessed on 2024 Jun 27].
Tramèr MR, Carroll D, Campbell FA, Reynolds DJ, Moore RA,
McQuay HJ. Cannabinoids for control of chemotherapy induced nausea
and vomiting: Quantitative systematic review. BMJ 2001;323:16-21.
Chang HR, Dulloo AG, Bistrian BR. Role of cytokines in AIDS
wasting. Nutrition 1998;14:853-63.
Wong BS, Camilleri M, Eckert D, Carlson P, Ryks M, Burton D,
et al. Randomized pharmacodynamic and pharmacogenetic trial
of dronabinol effects on colon transit in irritable bowel syndrome-
diarrhea. Neurogastroenterol Motil 2012;24:358-e169. DOI:
1111/j.1365-2982.2011.01874.x
Available from: https://www.aans.org/en/patients/neurosurgical-
conditions-and-treatments/parkinsons-disease [Last accessed on
Jun 27].
Jinnah HA, Factor SA. Diagnosis and treatment of dystonia. Neurol
Clin 2015;33:77-100.
Parsons LH, Hurd YL. Endocannabinoid signalling in reward and
addiction. Nat Rev Neurosci 2015;16:579-94.
Vaillancourt R, Gallagher S, Cameron JD, Dhalla R. Cannabis use
in patients with insomnia and sleep disorders: Retrospective chart
review. Can Pharm J (Ott) 2022;155:175-80.
Available from: https://www.who.int/news-room/fact-sheets/detail/
schizophrenia [Last accessed on 2024 Jun 27].
Meena AK, Mangal AK, Rao MM, Panda P, Simha GV, Shakya SK,
et al. Evaluation of standardization parameters for sitopaladi churna
an ayurvedic formulation. Asian J Res Chem 2011;4:1867-71.